JP2006117662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006117662A5 JP2006117662A5 JP2005295271A JP2005295271A JP2006117662A5 JP 2006117662 A5 JP2006117662 A5 JP 2006117662A5 JP 2005295271 A JP2005295271 A JP 2005295271A JP 2005295271 A JP2005295271 A JP 2005295271A JP 2006117662 A5 JP2006117662 A5 JP 2006117662A5
- Authority
- JP
- Japan
- Prior art keywords
- anhydrogalactose
- formula
- suppression
- compound
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- IBZYPBGPOGJMBF-UHFFFAOYSA-N 3,6 anhydrogalactose Natural products CCC=CCC1C(CC(=O)NC(C(C)CC)C(O)=O)CCC1=O IBZYPBGPOGJMBF-UHFFFAOYSA-N 0.000 claims 8
- WZYRMLAWNVOIEX-BGPJRJDNSA-N 3,6-anhydro-D-galactose Chemical compound O=C[C@H](O)[C@H]1OC[C@@H](O)[C@@H]1O WZYRMLAWNVOIEX-BGPJRJDNSA-N 0.000 claims 8
- DCQFFOLNJVGHLW-UHFFFAOYSA-N 4'-Me ether-Punctatin+ Natural products O1C(O)C(O)C2OCC1C2O DCQFFOLNJVGHLW-UHFFFAOYSA-N 0.000 claims 8
- WZYRMLAWNVOIEX-UHFFFAOYSA-N cinnamtannin B-2 Natural products O=CC(O)C1OCC(O)C1O WZYRMLAWNVOIEX-UHFFFAOYSA-N 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 8
- 230000001629 suppression Effects 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 4
- 230000006698 induction Effects 0.000 claims 4
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- JPLATTLXZFUKRQ-UHFFFAOYSA-N Agarobiose Natural products OCC1OC(OC2C(O)COC2C(O)C=O)C(O)C(O)C1O JPLATTLXZFUKRQ-UHFFFAOYSA-N 0.000 claims 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 210000002437 synoviocyte Anatomy 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 230000014616 translation Effects 0.000 claims 2
- 229920001817 Agar Polymers 0.000 claims 1
- 229920000936 Agarose Polymers 0.000 claims 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 239000008272 agar Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 230000007515 enzymatic degradation Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005295271A JP2006117662A (ja) | 1998-06-09 | 2005-10-07 | 治療剤 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17529598 | 1998-06-09 | ||
| JP22372398 | 1998-07-24 | ||
| JP1163999 | 1999-01-20 | ||
| JP2005295271A JP2006117662A (ja) | 1998-06-09 | 2005-10-07 | 治療剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000553433A Division JP3779153B2 (ja) | 1998-06-09 | 1999-06-08 | 治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006117662A JP2006117662A (ja) | 2006-05-11 |
| JP2006117662A5 true JP2006117662A5 (https=) | 2006-06-22 |
Family
ID=27279509
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000553433A Expired - Fee Related JP3779153B2 (ja) | 1998-06-09 | 1999-06-08 | 治療剤 |
| JP2005295271A Pending JP2006117662A (ja) | 1998-06-09 | 2005-10-07 | 治療剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000553433A Expired - Fee Related JP3779153B2 (ja) | 1998-06-09 | 1999-06-08 | 治療剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6531148B1 (https=) |
| EP (1) | EP1086952B1 (https=) |
| JP (2) | JP3779153B2 (https=) |
| KR (3) | KR100735139B1 (https=) |
| CN (1) | CN1131867C (https=) |
| AT (1) | ATE370144T1 (https=) |
| AU (1) | AU764582B2 (https=) |
| CA (1) | CA2334249A1 (https=) |
| DE (1) | DE69936855T2 (https=) |
| TW (1) | TWI244484B (https=) |
| WO (1) | WO1999064424A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001181191A (ja) * | 1999-12-24 | 2001-07-03 | Cci Corp | 慢性関節リウマチ疾患予防および治療剤 |
| US20030158250A1 (en) * | 2000-01-13 | 2003-08-21 | Tatsuji Enoki | Agents correcting gene expression regulatory error |
| WO2002029099A1 (fr) * | 2000-10-03 | 2002-04-11 | Takara Bio Inc. | Technique de criblage de substance physiologiquement active |
| KR100373776B1 (ko) * | 2000-12-27 | 2003-02-26 | 한불화장품주식회사 | 화장료 조성물 |
| CH692180A5 (it) * | 2001-06-22 | 2002-03-15 | Gecomwert Anstalt | Preparato cosmetico con azione antirughe. |
| WO2003024446A1 (en) * | 2001-09-11 | 2003-03-27 | Mitsubishi Pharma Corporation | Oxidation stress inhibitor and method of measuring oxidation stress |
| US20050063995A1 (en) * | 2001-10-25 | 2005-03-24 | Spaner David E | Compositions and methods for selected tumour treatment |
| AU2003236239A1 (en) * | 2002-04-17 | 2003-10-27 | Takara Bio Inc. | Remedies |
| US7309589B2 (en) | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
| EP2308324A1 (en) * | 2005-05-31 | 2011-04-13 | Arla Foods amba | Phosphatidylserine enriched milk fractions for the formulation of functional foods |
| WO2012148023A1 (ko) * | 2011-04-29 | 2012-11-01 | 바이올시스템즈 주식회사 | 무수갈락토스의 분리정제 방법 |
| CN102321153B (zh) * | 2011-09-06 | 2013-06-05 | 中国科学院成都生物研究所 | 一种新奥苷肽粉状固体的制备方法 |
| US20150216778A1 (en) * | 2012-01-18 | 2015-08-06 | Korea University Research And Business Foundation | Method for Preparing 3,6-Anhydro-L-Galactose, And Use Thereof |
| JP6241644B2 (ja) * | 2013-06-05 | 2017-12-06 | 伊那食品工業株式会社 | ＰＰＡＲγ発現向上剤、並びにそれを含む基礎代謝向上剤、筋肉疲労回復向上剤、ＰＰＡＲγ発現向上用医薬組成物及びＰＰＡＲγ発現向上用飲食品 |
| KR102011721B1 (ko) * | 2017-11-28 | 2019-08-19 | 고려대학교 산학협력단 | 포도상구균의 생육을 억제하는 한천 유래 올리고당의 용도 |
| CN108776121B (zh) * | 2018-04-08 | 2021-07-30 | 广州卡马生物科技有限公司 | 一种基于荧光猝灭原理对药材中抗氧剂的高通量筛选方法 |
| CN112375110A (zh) * | 2020-11-20 | 2021-02-19 | 西安乐析医疗科技有限公司 | 一种化合物3,4-dge的制备方法 |
| KR102608602B1 (ko) * | 2020-11-27 | 2023-12-01 | (주)헬스코치생명공학 | Ahg를 이용한 자외선에 의한 피부 주름 개선용 조성물 |
| KR102537335B1 (ko) * | 2022-08-10 | 2023-05-26 | 경북대학교 산학협력단 | Ｌａｈｇ를 포함하는 면역 억제용 조성물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1202286B (de) * | 1962-08-04 | 1965-10-07 | Huels Chemische Werke Ag | Verfahren zur Herstellung von beta-Pyronen |
| US3230233A (en) * | 1964-03-04 | 1966-01-18 | American Cyanamid Co | Novel substituted 2, 3-dihydro-9-carbamo-yloxymethyl-6-methyl-pyrrolo[1, 2-a] indole-5, 8-diones |
| FR2541307A1 (fr) * | 1983-02-23 | 1984-08-24 | Korano | Substance gelifiante semi-synthetique, son procede de preparation et ses applications, notamment dans les milieux de culture pour microorganismes |
| JPS62210958A (ja) * | 1986-03-13 | 1987-09-17 | Meiji Seika Kaisha Ltd | 澱粉含有組成物の老化防止方法 |
| JPH04316593A (ja) * | 1991-02-21 | 1992-11-06 | Japan Tobacco Inc | Ｄ−アロサンの製造方法 |
| JPH05565A (ja) * | 1991-06-21 | 1993-01-08 | Toyo Ink Mfg Co Ltd | 皮膜形成方法 |
| US5380834A (en) * | 1992-02-06 | 1995-01-10 | Ishihara Sangyo Kaisha Ltd. | Immuno-suppressive agent |
| EP0570252A3 (en) * | 1992-05-15 | 1994-02-23 | Ina Food Ind Co Ltd | Low gel strength agar-agar |
| CA2121148A1 (en) * | 1992-08-19 | 1994-03-03 | Otsuka Pharmaceutical Co., Ltd. | Apoptosis regulator |
| JP3193480B2 (ja) * | 1992-09-03 | 2001-07-30 | 石原産業株式会社 | 免疫機能抑制剤 |
| JP3266343B2 (ja) | 1992-12-17 | 2002-03-18 | 芝浦メカトロニクス株式会社 | クリームはんだ印刷装置 |
| JP3865801B2 (ja) * | 1995-04-27 | 2007-01-10 | 株式会社ヤクルト本社 | 新規なβ−アガラーゼ，その製造方法及びその用途 |
| US5834257A (en) * | 1995-11-06 | 1998-11-10 | Japan Tobacco Inc. | α-agarase and production process of oligosaccharides and monosaccharides |
| AU727026B2 (en) * | 1996-11-08 | 2000-11-30 | Takara Bio Inc. | Apoptosis inducing agent |
| ATE303354T1 (de) * | 1998-01-19 | 2005-09-15 | Takara Bio Inc | Substanzen, welche apoptose einleiten können |
-
1999
- 1999-06-07 TW TW088109429A patent/TWI244484B/zh active
- 1999-06-08 DE DE69936855T patent/DE69936855T2/de not_active Expired - Fee Related
- 1999-06-08 EP EP99923961A patent/EP1086952B1/en not_active Expired - Lifetime
- 1999-06-08 KR KR1020067021143A patent/KR100735139B1/ko not_active Expired - Fee Related
- 1999-06-08 WO PCT/JP1999/003058 patent/WO1999064424A1/ja not_active Ceased
- 1999-06-08 US US09/719,314 patent/US6531148B1/en not_active Expired - Fee Related
- 1999-06-08 CN CN99809417XA patent/CN1131867C/zh not_active Expired - Fee Related
- 1999-06-08 CA CA002334249A patent/CA2334249A1/en not_active Abandoned
- 1999-06-08 AT AT99923961T patent/ATE370144T1/de not_active IP Right Cessation
- 1999-06-08 KR KR1020067013109A patent/KR100696404B1/ko not_active Expired - Fee Related
- 1999-06-08 KR KR1020007013293A patent/KR100620409B1/ko not_active Expired - Fee Related
- 1999-06-08 AU AU40606/99A patent/AU764582B2/en not_active Ceased
- 1999-06-08 JP JP2000553433A patent/JP3779153B2/ja not_active Expired - Fee Related
-
2005
- 2005-10-07 JP JP2005295271A patent/JP2006117662A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006117662A5 (https=) | ||
| CA2606719A1 (en) | Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same | |
| EP4282416A3 (en) | Process of manufacture of a compound for inhibiting the activity of shp2 | |
| WO2005090333A8 (en) | 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
| WO2025019346A3 (en) | Methods of use of a liposomal composition comprising an atr inhibitor | |
| WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
| JP2008526765A5 (https=) | ||
| WO2009150137A3 (en) | Pyrazine derivatives as epithelial sodium channel blockers | |
| CA2679925A1 (en) | Method for producing high-purity prasugrel hydrochloride | |
| NZ603332A (en) | Sweet flavor modifier | |
| TN2012000413A1 (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
| WO2005007081A3 (en) | Compounds and methods for delivery of prostacyclin analogs | |
| WO2010141796A3 (en) | PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES | |
| EA025437B1 (ru) | Соединения, ингибирующие металлоферменты | |
| SK91195A3 (en) | Azetidinones substituted with spirocycloalkyl group, their use and method of their production, pharmaceutical agent containing these substituted azetidinones substituted, method of its production and set containing this agent | |
| WO2010005958A3 (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
| IL144636A0 (en) | Thioamide derivatives | |
| WO2010077101A3 (ko) | 신규한 티아졸리딘디온 유도체 및 그의 용도 | |
| WO2024006726A3 (en) | Compounds as inhibitors of axl | |
| WO2009071082A9 (en) | Rna antagonist compounds for the modulation of pik3ca expression | |
| WO2005002519A3 (en) | Amphiphilic pyridinium compounds, method of making and use thereof | |
| CA2647346A1 (en) | Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | |
| WO2011004389A3 (en) | An improved process for the preparation of elvitegravir | |
| MX2009006692A (es) | Derivados de prostaciclina. | |
| EP2772481A8 (en) | Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |